Company Filing History:
2 out of 1,866 
1 out of 46 Years Active: 1982-1990
Title: Tadayuki Yamane: Innovator in Blood Treatment Technologies
Introduction
Tadayuki Yamane is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of blood treatment technologies, holding 2 patents that focus on innovative methods for plasma separation and blood purification.
Latest Patents
One of his latest patents is an "Apparatus and method for plasma separation." This invention provides a system designed to separate blood into plasma and corpuscular components using plasma separation membranes. The apparatus adjusts the number of revolutions of a plasma pump to maintain an optimal trans-membrane pressure differential, ensuring effective performance of the membranes. This method is particularly useful in various blood treatment applications aimed at removing pathogenic factors from plasma.
Another significant patent is "Blood purification using plural ultrafiltration stages." This invention realizes double-step-membrane filtration, separating blood into plasma and corpuscular fractions while also distinguishing high-molecular-weight substances from low-molecular-weight substances in the plasma. This method is effective for treating patients with conditions such as peripheral circulatory insufficiency and rheumatoid arthritis.
Career Highlights
Throughout his career, Tadayuki Yamane has worked with prominent companies, including Kuraray Co., Ltd. and Kawasumi Laboratories, Inc. His work has significantly advanced the field of blood treatment, showcasing his dedication to improving medical technologies.
Collaborations
Tadayuki has collaborated with notable coworkers, including Yoshimichi Harada and Kenji Kubota. Their combined expertise has contributed to the development of innovative solutions in blood treatment.
Conclusion
Tadayuki Yamane's contributions to blood treatment technologies through his patents demonstrate his commitment to advancing medical science. His innovative approaches have the potential to improve patient outcomes and enhance the effectiveness of blood treatment methods.